Please join us for RegenMed, Inc. Investors Webinar, Monday, December 16 at 6:30 PM, New York time.

RegenMed's CEO Michael P Tierney will review the Company's momentum through the end of the year, as well as expectations for 2025.

For more information, see our Investors Page.

_{This Reg CF offering is made available through StartEngine Primary LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. The webinar may contain forward-looking statements based on current expectations. Actual results could differ significantly due to various risks and uncertainties.}